ACHV
Achieve Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$8.49
+2.17%0
Insider buys (3m)
1
Insider sells (3m)
-$175.2K
Net value (3m)
+63.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 21, 2026 | Stewart Richard Alistair · director | Sale | 20,626 | $8.49 |
| Jul 29, 2026 | Royston Aaron · director | A-Award | 25,000 | $6.18 |
| Jul 29, 2026 | Waldman Reid Alexander · director | A-Award | 16,700 | $0.00 |
| Jul 29, 2026 | Stewart Richard Alistair · director | A-Award | 25,000 | $6.18 |
| Jul 29, 2026 | Martin Christopher Nathan · director | A-Award | 25,000 | $6.18 |
| Jul 29, 2026 | Stewart Richard Alistair · director | A-Award | 16,700 | $0.00 |
| Jul 29, 2026 | Sellig Thomas · director | A-Award | 16,700 | $0.00 |
| Jul 29, 2026 | Farrow Jeffrey S · director | A-Award | 16,700 | $0.00 |
| Jul 29, 2026 | Farrow Jeffrey S · director | A-Award | 25,000 | $6.18 |
| Jul 29, 2026 | Phelan Nancy R. · director | A-Award | 16,700 | $0.00 |
| Jul 29, 2026 | Phelan Nancy R. · director | A-Award | 25,000 | $6.18 |
| Jul 29, 2026 | Martin Christopher Nathan · director | A-Award | 16,700 | $0.00 |
| Jul 29, 2026 | Sellig Thomas · director | A-Award | 25,000 | $6.18 |
| Jul 29, 2026 | Royston Aaron · director | A-Award | 16,700 | $0.00 |
| Jul 29, 2026 | Waldman Reid Alexander · director | A-Award | 25,000 | $6.18 |
| Jun 2, 2026 | Waldman Reid Alexander · director | A-Award | 47,250 | $5.24 |
| Jun 2, 2026 | Farrow Jeffrey S · director | A-Award | 47,250 | $5.24 |
| May 13, 2026 | Martin Christopher Nathan · director | A-Award | 47,250 | $5.59 |
| Apr 21, 2026 | Goldberg Andrew D. · director, officer: CEO and President | A-Award | 1,800,965 | $0.00 |
| Apr 21, 2026 | Goldberg Andrew D. · director, officer: CEO and President | A-Award | 11,706,270 | $0.00 |
| Apr 21, 2026 | Goldberg Andrew D. · director, officer: CEO and President | A-Award | 3,601,929 | $4.25 |
| Jan 30, 2026 | Xinos Jaime · officer: Chief Commercial Officer | A-Award | 180,000 | $4.36 |
| Jan 30, 2026 | Rubinstein Mark Lawrence · officer: Chief Medical Officer | A-Award | 180,000 | $4.36 |
| Jan 30, 2026 | Wan Jerry · officer: Principal Accounting Officer | A-Award | 70,300 | $4.36 |
| Jan 30, 2026 | Stewart Richard Alistair · director, officer: Chief Executive Officer | A-Award | 645,000 | $4.36 |
| Jan 30, 2026 | Oki Mark K · officer: Chief Financial Officer | A-Award | 180,000 | $4.36 |
| Jan 30, 2026 | Donnelly Craig · officer: Chief Operations Officer | A-Award | 180,000 | $4.36 |
| Dec 8, 2025 | Atkisson Erik · officer: Chief Legal Officer | A-Award | 250,000 | $4.78 |
| Oct 3, 2025 | Donnelly Craig · officer: Chief Operations Officer | A-Award | 50,000 | $3.10 |
| Sep 22, 2025 | Stewart Richard Alistair · director, officer: Chief Executive Officer | Sale | 129,501 | $2.92 |
Institutional positioning
13F filings over the trailing two quarters
New 17Increased 20Reduced 26Sold out 80
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FRANKLIN RESOURCES INC | Unchanged | 4,369,193 | May 13, 2026 |
| PROPEL BIO MANAGEMENT, LLC | Unchanged | 3,786,425 | May 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,204,714 | May 15, 2026 |
| SIMPLIFY ASSET MANAGEMENT INC. | Unchanged | 1,184,512 | Apr 27, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 1,077,338 | May 15, 2026 |
| MARSHALL WACE, LLP | Unchanged | 1,019,281 | May 15, 2026 |
| LPL FINANCIAL LLC | Increased | 728,448 | May 6, 2026 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | Unchanged | 648,885 | May 15, 2026 |
| RAYMOND JAMES FINANCIAL INC | Increased | 641,925 | May 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 622,785 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Reduced | 588,551 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 510,883 | May 15, 2026 |
| KVP Capital Advisors, LP | Unchanged | 462,355 | May 13, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 450,928 | Mar 25, 2026 |
| BLACKROCK, INC. | Increased | 439,360 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 21, 2026